Information  X 
Enter a valid email address

Oxford Biomedica PLC Ord 1P (OXB)

Date Time Source Announcement
13 Nov 2019 4:41 pm
RNS
Holding(s) in Company
01 Nov 2019 9:25 am
RNS
Total Voting Rights
28 Oct 2019 12:30 pm
RNS
Director Dealings / Market Share Purchase
23 Oct 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
16 Oct 2019 7:30 am
EQS
Oxford BioMedica (OXB): Demanding second half
01 Oct 2019 10:18 am
RNS
Total Voting Rights
25 Sep 2019 11:41 am
RNS
Director Dealings / Market Share Purchase
16 Sep 2019 11:18 am
RNS
Director/PDMR Shareholding
  9:15 am
RNS
Directors Dealings / Market Share Purchases
13 Sep 2019 2:57 pm
RNS
Long Term Incentive Plan Option Grant
  1:13 pm
RNS
Directors Dealings / Market Share Purchases
  10:53 am
RNS
Director Dealings / Market Share Purchase
04 Sep 2019 7:00 am
RNS
Oxford Biomedica Interim Results
02 Sep 2019 9:31 am
RNS
Total Voting Rights
23 Aug 2019 11:06 am
RNS
Director Dealings / Market Share Purchase
09 Aug 2019 12:00 pm
RNS
Notice of Interim Results
01 Aug 2019 9:18 am
RNS
Total Voting Rights
25 Jul 2019 2:17 pm
RNS
Director Dealings / Market Share Purchase
01 Jul 2019 11:03 am
EQS
Oxford BioMedica (OXB): Eying up long-term value
  10:01 am
RNS
Block listing Interim Review
  9:32 am
RNS
Total Voting Rights
28 Jun 2019 7:00 am
RNS
Repayment of Debt Facility
26 Jun 2019 2:52 pm
RNS
Director Dealings / Market Share Purchase
  7:00 am
RNS
OXB and Santen enter R&D collaboration
25 Jun 2019 7:00 am
RNS
Board Change
18 Jun 2019 7:15 am
EQS
Oxford BioMedica (OXB): De-leveraging the balance sheet
10 Jun 2019 2:34 pm
RNS
Director/PDMR Shareholding
06 Jun 2019 1:08 pm
RNS
Axovant update on 1st cohort of Sunrise-PD trial
  11:39 am
RNS
Holding(s) in Company
05 Jun 2019 12:06 pm
RNS
Holdings in Company
04 Jun 2019 5:38 pm
RNS
Holdings in Company
  9:59 am
RNS
Total Voting Rights
03 Jun 2019 6:06 pm
RNS
Holding(s) in Company
  10:31 am
RNS
Total Voting Rights
29 May 2019 6:19 pm
RNS
Exercise of Subscription Option by Novo Holdings
  1:06 pm
RNS
Result of AGM
28 May 2019 7:00 am
RNS
Strategic Investment by Novo Holdings A/S
23 May 2019 6:04 pm
RNS
Director Dealings / Market Share Purchase
02 May 2019 2:53 pm
RNS
Long Term Incentive Plan Option Grant
01 May 2019 12:52 pm
RNS
REPLACEMENT: Total Voting Rights
30 Apr 2019 5:38 pm
RNS
Holdings in Company
  1:35 pm
RNS
Oxford Biomedica to present at the ASGCT
  1:15 pm
RNS
Axovant doses second cohort of AXO-Lenti-PD
25 Apr 2019 3:38 pm
RNS
Director Dealings / Market Share Purchase
23 Apr 2019 1:47 pm
RNS
Deferred Bonus Plan and LTIP Option Grants
  11:38 am
RNS
Director Dealings / Market Share Transactions
18 Apr 2019 5:33 pm
RNS
Exercise of warrants
  7:00 am
RNS
Annual Report and Accounts & AGM Notification
02 Apr 2019 7:15 am
EQS
Oxford BioMedica (OXB): Deal-making drives first annual profit
01 Apr 2019 11:40 am
RNS
Total Voting Rights
26 Mar 2019 12:57 pm
RNS
Director Dealings / Market Share Purchase
  8:25 am
RNS
Japanese approval of Kymriah? (tisagenlecleucel)
14 Mar 2019 7:00 am
RNS
Preliminary Results
12 Mar 2019 7:00 am
RNS
OXB announces R&D collaboration with Microsoft
11 Mar 2019 10:38 am
RNS
Axovant's update on Phase 2 trial of AXO-Lenti-PD
01 Mar 2019 9:30 am
RNS
Total Voting Rights
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t